Enovis Sets Sights on $2 Billion in 2024

Enovis reported 1Q22 orthopedic sales of $146 million, +61.5% vs. 1Q21. By 2024, the company expects to achieve sustainable high single-digit growth and $2 billion in annual sales.

The company vastly expanded its geographic footprint with the mid-2021 purchase of Mathys. It also assembled a foot and ankle business through the acquisitions of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us